Informazione:
Errore:
ID
23207
Descrizione
Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg; ODM derived from: https://clinicaltrials.gov/show/NCT00529451
collegamento
https://clinicaltrials.gov/show/NCT00529451
Keywords
versioni (1)
- 28/06/17 28/06/17 -
Caricato su
28 giugno 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Hypertension NCT00529451
Eligibility Hypertension NCT00529451
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00529451
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
ID.1
Item
patients must have msdbp ≥ 90 mmhg and < 110 mmhg at the visit immediately prior to visit 3
boolean
C0005823 (UMLS CUI [1])
ID.2
Item
patients must have msdbp >or= 95 mmhg and < 110 mmhg at visit 3
boolean
C0005823 (UMLS CUI [1])
ID.3
Item
patients must have an absolute difference of < or =10 mmhg in their mean sitting diastolic blood pressure (msdbp) from visit 2 to visit 3
boolean
C0005823 (UMLS CUI [1,1])
C1705241 (UMLS CUI [1,2])
C1705241 (UMLS CUI [1,2])
ID.4
Item
severe hypertension (grade 3 who classification; msdbp >or= 110 mmhg and/or mssbp >or = 180 mmhg).
boolean
C4013784 (UMLS CUI [1])
ID.5
Item
history or evidence of a secondary form of hypertension.
boolean
C0155616 (UMLS CUI [1])
ID.6
Item
history of transient ischemic cerebral attack within 12 months of visit 1.
boolean
C0007787 (UMLS CUI [1])
ID.7
Item
current angina pectoris requiring pharmacological therapy (other than those patients on a stable dose of oral or topical nitrates)
boolean
C0002962 (UMLS CUI [1])
ID.8
Item
type 1 or type 2 diabetes mellitus with glycosylated hemoglobin (hba1c) > 8% at visit 1.
boolean
C0011849 (UMLS CUI [1])
ID.9
Item
known or suspected contraindications to the study medications, including history of allergy to ramipril or other ace inhibitors.
boolean
C0683526 (UMLS CUI [1,1])
C0571943 (UMLS CUI [1,2])
C0571939 (UMLS CUI [1,3])
C0571943 (UMLS CUI [1,2])
C0571939 (UMLS CUI [1,3])
ID.10
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
C0680251 (UMLS CUI [1,2])